Treatment of chronic urticaria with omalizumab: the experience of Hospital de Braga

Treatment of chronic urticaria with omalizumab: the experience of Hospital de Braga

Introduction: Omalizumab is approved for the treatment of severe chronic spontaneous urticaria (CSU), unresponsive to quadruple doses of nonsedative H1 antihistamine. Few data are available to help predict the response to omalizumab in the Portuguese population. Objective: Characterize the populatio...

Full description

Saved in:
Bibliographic Details
Main Authors: Ana G. Lopes (Author), Marianlie Navarro (Author), Carmem Botelho (Author), Maria J. Guimarães (Author), Catarina Cerqueira (Author), Joana Gomes (Author), Celeste Brito (Author)
Format: Book
Published: Sociedade Portuguesa de Dermatologia e Venereologia, 2022-10-01T00:00:00Z.
Subjects:
article
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available

Similar Items